BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25715695)

  • 1. Quantitative Evaluation of mMate1 Function Based on Minimally Invasive Measurement of Tissue Concentration Using PET with [(11)C]Metformin in Mouse.
    Shingaki T; Hume WE; Takashima T; Katayama Y; Okauchi T; Hayashinaka E; Wada Y; Cui Y; Kusuhara H; Sugiyama Y; Watanabe Y
    Pharm Res; 2015 Aug; 32(8):2538-47. PubMed ID: 25715695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine.
    Ito S; Kusuhara H; Kuroiwa Y; Wu C; Moriyama Y; Inoue K; Kondo T; Yuasa H; Nakayama H; Horita S; Sugiyama Y
    J Pharmacol Exp Ther; 2010 Apr; 333(1):341-50. PubMed ID: 20065018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
    Müller F; Pontones CA; Renner B; Mieth M; Hoier E; Auge D; Maas R; Zolk O; Fromm MF
    Eur J Clin Pharmacol; 2015 Jan; 71(1):85-94. PubMed ID: 25552403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of atenolol on urinary excretion of metformin via down-regulating multidrug and toxin extrusion protein 1 (rMate1) expression in the kidney of rats.
    Ma YR; Huang J; Shao YY; Ma K; Zhang GQ; Zhou Y; Zhi R; Qin HY; Wu XA
    Eur J Pharm Sci; 2015 Feb; 68():18-26. PubMed ID: 25486332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The synthesis and biodistribution of [(11)C]metformin as a PET probe to study hepatobiliary transport mediated by the multi-drug and toxin extrusion transporter 1 (MATE1) in vivo.
    Hume WE; Shingaki T; Takashima T; Hashizume Y; Okauchi T; Katayama Y; Hayashinaka E; Wada Y; Kusuhara H; Sugiyama Y; Watanabe Y
    Bioorg Med Chem; 2013 Dec; 21(24):7584-90. PubMed ID: 24238901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A PET Tracer for Renal Organic Cation Transporters, ¹¹C-Metformin: Radiosynthesis and Preclinical Proof-of-Concept Studies.
    Jakobsen S; Busk M; Jensen JB; Munk OL; Zois NE; Alstrup AK; Jessen N; Frøkiær J
    J Nucl Med; 2016 Apr; 57(4):615-21. PubMed ID: 26769859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organic cation transporter and multidrug and toxin extrusion 1 co-mediated interaction between metformin and berberine.
    Shi R; Xu Z; Xu X; Jin J; Zhao Y; Wang T; Li Y; Ma Y
    Eur J Pharm Sci; 2019 Jan; 127():282-290. PubMed ID: 30428337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [11C]-Labeled Metformin Distribution in the Liver and Small Intestine Using Dynamic Positron Emission Tomography in Mice Demonstrates Tissue-Specific Transporter Dependency.
    Jensen JB; Sundelin EI; Jakobsen S; Gormsen LC; Munk OL; Frøkiær J; Jessen N
    Diabetes; 2016 Jun; 65(6):1724-30. PubMed ID: 26993065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of the multidrug and toxin extrusion (MATE) transporter by pyrimethamine increases the plasma concentration of metformin but does not increase antihyperglycaemic activity in humans.
    Oh J; Chung H; Park SI; Yi SJ; Jang K; Kim AH; Yoon J; Cho JY; Yoon SH; Jang IJ; Yu KS; Chung JY
    Diabetes Obes Metab; 2016 Jan; 18(1):104-8. PubMed ID: 26381793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Oatp and Mrp2 activities in hepatobiliary excretion using newly developed positron emission tomography tracer [11C]dehydropravastatin in rats.
    Shingaki T; Takashima T; Ijuin R; Zhang X; Onoue T; Katayama Y; Okauchi T; Hayashinaka E; Cui Y; Wada Y; Suzuki M; Maeda K; Kusuhara H; Sugiyama Y; Watanabe Y
    J Pharmacol Exp Ther; 2013 Oct; 347(1):193-202. PubMed ID: 23926287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Clinical Quantitative Evaluation of Hepatobiliary Transport of [
    Kaneko K; Tanaka M; Ishii A; Katayama Y; Nakaoka T; Irie S; Kawahata H; Yamanaga T; Wada Y; Miyake T; Toshimoto K; Maeda K; Cui Y; Enomoto M; Kawamura E; Kawada N; Kawabe J; Shiomi S; Kusuhara H; Sugiyama Y; Watanabe Y
    Drug Metab Dispos; 2018 May; 46(5):719-728. PubMed ID: 29555827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of high uric acid on the disposition of metformin: in vivo and in vitro studies.
    Zhang G; Ma Y; Xi D; Rao Z; Sun X; Wu X
    Biopharm Drug Dispos; 2019 Jan; 40(1):3-11. PubMed ID: 30488476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin.
    Tsuda M; Terada T; Mizuno T; Katsura T; Shimakura J; Inui K
    Mol Pharmacol; 2009 Jun; 75(6):1280-6. PubMed ID: 19332510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effect of testosterone and oestrogen on urinary excretion of metformin via regulating OCTs and MATEs expression in the kidney of mice.
    He R; Ai L; Zhang D; Wan L; Zheng T; Yin J; Lu H; Lu J; Lu F; Liu F; Jia W
    J Cell Mol Med; 2016 Dec; 20(12):2309-2317. PubMed ID: 27469532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy Increases the Renal Secretion of N
    Bergagnini-Kolev MC; Hebert MF; Easterling TR; Lin YS
    Drug Metab Dispos; 2017 Mar; 45(3):325-329. PubMed ID: 28069720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical Synthesis of [
    Nakaoka T; Uetake Y; Kaneko KI; Niwa T; Ochiai H; Irie S; Suezaki Y; Otsuka N; Hayashinaka E; Wada Y; Cui Y; Maeda K; Kusuhara H; Sugiyama Y; Hosoya T; Watanabe Y
    Mol Pharm; 2020 Jun; 17(6):1884-1898. PubMed ID: 32271581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of a MATE protein inhibitor, pyrimethamine, on the renal elimination of metformin at oral microdose and at therapeutic dose in healthy subjects.
    Kusuhara H; Ito S; Kumagai Y; Jiang M; Shiroshita T; Moriyama Y; Inoue K; Yuasa H; Sugiyama Y
    Clin Pharmacol Ther; 2011 Jun; 89(6):837-44. PubMed ID: 21544077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin and cimetidine: Physiologically based pharmacokinetic modelling to investigate transporter mediated drug-drug interactions.
    Burt HJ; Neuhoff S; Almond L; Gaohua L; Harwood MD; Jamei M; Rostami-Hodjegan A; Tucker GT; Rowland-Yeo K
    Eur J Pharm Sci; 2016 Jun; 88():70-82. PubMed ID: 27019345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Appropriate Endogenous Biomarker for Risk Assessment of Multidrug and Toxin Extrusion Protein-Mediated Drug-Drug Interactions in Healthy Volunteers.
    Miyake T; Kimoto E; Luo L; Mathialagan S; Horlbogen LM; Ramanathan R; Wood LS; Johnson JG; Le VH; Vourvahis M; Rodrigues AD; Muto C; Furihata K; Sugiyama Y; Kusuhara H
    Clin Pharmacol Ther; 2021 Feb; 109(2):507-516. PubMed ID: 32866300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of Altered Metformin Distribution in Nonalcoholic Steatohepatitis.
    Clarke JD; Dzierlenga AL; Nelson NR; Li H; Werts S; Goedken MJ; Cherrington NJ
    Diabetes; 2015 Sep; 64(9):3305-13. PubMed ID: 26016715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.